Drug Shortage Report for THALLOUS CHLORIDE TI-201 INJECTION

Last updated on 2024-04-10 History
Report ID 171882
Drug Identification Number 02328925
Brand name THALLOUS CHLORIDE TI-201 INJECTION
Common or Proper name thallous chloride Tl201 injection
Company Name CURIUM CANADA INC
Market Status MARKETED
Active Ingredient(s) THALLIUM CHLORIDE
Strength(s) 37MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2.8 to 9.9 mCi
ATC code V09GX
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-10-07
Actual start date 2022-10-07
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-04-10
Company comments Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Please also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period.
Health Canada comments
Tier 3 Status No
Contact Address 2572 BOUL. DANIEL-JOHNSON
LAVAL, QUEBEC
CANADA H7T 2R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-04-10 French Compare
v15 2024-04-10 English Compare
v14 2024-01-02 French Compare
v13 2024-01-02 English Compare
v12 2024-01-02 French Compare
v11 2024-01-02 English Compare
v10 2023-12-08 French Compare
v9 2023-12-08 English Compare
v8 2022-11-21 French Compare
v7 2022-11-21 English Compare
v6 2022-10-24 French Compare
v5 2022-10-24 English Compare
v4 2022-10-24 English Compare
v3 2022-10-17 French Compare
v2 2022-10-17 French Compare
v1 2022-10-17 English Compare

Showing 1 to 16 of 16